Surging Geriatric Population Driving Sales of Osteoporosis Drugs in Asia-Pacific
For more insights:- https://www.psmarketresearch.com/market-analysis/osteoporosis-drugs-market
Human skeleton has changed drastically during the thousands of years of evolution. According to the research pubished in the PNAS (Proceedings of the National Academy of Sciences of the United States of America), a multidisciplinary science journal, the advent of agriculture and the subsequent change of human lifestyles from hunter-gatherers to farming-based have caused a considerable reduction in the weight of the human skeleton. Moreover, this has caused a sharp reduction in the bone densities of humans.
Apart from causing a major change in diets, agriculture also reduced the human dependence on running and walking for surviving, which, in turn, caused a huge reduction in the physical capabilities of humans including their bone strength. The advent of machines, the rise of industries and urbanization, and the advent of computers have further reduced the human dependence on physical labor for survival and as a result, our skeletons becoming progressively weaker with each passing generation.
According to the World Health Organization (WHO), over 50% of the population in the world currently live in urban areas and this share is predicted to rise to 70% by 2050. This rapid urbanization is giving rise to sedentary lifestyles and unhealthy eating habits, which are, in turn, fueling the rise in the prevalence of osteoporosis across the world. Osteoporosis is a bone condition that occurs when the human body makes too little bone or loses too much bone.
This condition drastically increases the chances of bone fractures and therefore, requires immediate medical treatment. As osteoporosis drugs are widely used for treating this disorder, the growing incidence of this disease is pushing up the requirement for osteoporosis drugs all over the world. Many research organizations and academic institutions are making huge investments for facilitating faster discovery and development of osteoporosis drugs, because of the rising need for enhanced osteoporosis care and the ballooning public awareness about these drugs.
Hence, with the mushrooming sales of osteoporosis drugs around the world, the global osteoporosis drugs market will exhibit huge expansion in the coming years, as per the estimates of P&S Intelligence, a market research firm. Selective estrogen receptor modulator (SERM), calcitonin, bisphosphonates, rank ligand inhibitor, and parathyroid hormone therapy are the most commonly used types of osteoporosis drug classes. Amongst these, the sales of the bisphosphonates drug class were observed to be considerably high in the years gone by.
Globally, the North American osteoporosis drugs market is currently very prosperous and is predicted to exhibit lucrative growth in the future years. According to industry experts, the sales of osteoporosis drugs will rise tremendously in the Asia-Pacific (APAC) region in the forthcoming years, on account of the presence of a soaring geriatric population suffering from osteoporosis and the rising adoption of unhealthy lifestyles, which negatively impact the bone health of people.
Hence, it can be said with surety that due to the ballooning incidence of osteoporosis, on account of the growing adoption of unhealthy lifestyles and consumption of fast foods, the sales of osteoporosis drugs will climb all over the world in the upcoming years.